BCR and neoplasm: Indeed, it is now well known that selective inhibition of BTK (or PI3Kdelta) within the BCR (or CXCR4) pathways leads to peripheral lymphocytosis by disrupting the interaction between the TME and tumor B cell and their homing [8,17,33,34].